bluuebunny/crossref_metadata_2025_split huggingface dataset:
P043 RIPK3 – a new marker for assessment of activity in Crohn’s disease
Authors: Panayotova E , Atanassova A 
Published: January 2024

Abstract

Background
RIPK3 (Receptor Interacting Protein Kinase-3) is a key molecule involved in the process of necroptosis. Necroptosis is a regulated form of cell death that involves the activation of specific signaling pathways leading to cell lysis. The released endogenous molecules - DAMPs (Danger Associated Molecular Patterns) activate the immune system and lead to inflammation. This relationship suggests a role for necroptosis in the pathogenesis of IBD (Inflammatory Bowel Disease).

Methods
The aim of the study was to evaluate RIPK3 expression in patients with Crohn's disease (CD) according to disease activity and some clinical parameters. Tissue expression of RIPK3 in the inflamed areas of 85 patients with Crohn's disease was determined immunohistochemically. The CDAI (Crohn’s Disease Activity Index) was used to assess activity, and the Montreal Classification to determine disease location and bahavior.

Results
A correlation was found between RIPK3 expression and CDAI (p=0.038), with patients in remission having the lowest expression (154.67), while patients with severe activity had overexpression of the marker (180.0) (Fig.1).
According to the localization of CD, a significant difference was found in the expression of RIPK3 (p&lt;0.05), with the highest expression of the marker in the ileum (L1) and colon (L2) with involvement of the upper GIT (L4) – L1+L4 (225.50) and L2 + L4 (218.00). Isolated involvement of terminal ileum (L1) was characterized by the lowest expression of the marker, while patients with colonic localization (L2) had high expression of RIPK3 (184.87).
Regarding disease behavior, it was found that the highest expression of the marker is in the patients with phenotype B2+B3 – both stricturing and penetrating disease, followed by inflammatory disease (B1) (Fig.2). Perianal disease further increased RIPK3 expression, with patients with concurrent perianal disease showing high expression of the marker (181.85 vs. 167.86 for those without perianal disease; p&lt;0.05).

Conclusion
High RIPK3 expression in CD patients correlated with severe disease activity as measured by CDAI, involvement of upper GIT - L1+L4 and L2+L4, stricturing with penetrating disease - B2+B3 and concurrent perianal disease.
P049 The lipidome of creeping fat in Crohn’s disease points towards a harmful microenvironment
Authors: Verstockt S , Dehairs J , Vanderhoydonc F , Ke B J , De Greef I , Sabino J , Ferrante M , Bislenghi G , D’Hoore A , Swinnen J , Verstockt B , Vermeire S 
Published: January 2024

Abstract

Background
A pathognomonic observation in Crohn’s disease (CD) is the existence of mesenteric adipose tissue (MAT) wrapping around the inflamed and fibrotic intestine, so-called creeping fat. The etiology of this phenomenon is unclear, and both a protective and harmful role in disease pathogenesis and progression have been proposed. Given this conflicting evidence, we aimed to further unravel the role of creeping fat by extensive profiling of its lipidome.

Methods
We prospectively included 22 CD patients who underwent an ileocecal resection with ileocolonic anastomosis (Table 1). Perioperatively paired adipose tissue samples were collected from 3 locations: (1) creeping fat, (2) MAT close to the proximal unaffected ileum, and (3) MAT far from the diseased ileum, defined as near the base of the ileocecal artery (Fig. 1A). The lipidome of all 66 samples was profiled by quantitative mass spectrometry (targeted C18 LC-MS/MS and HILIC LC-MS/MS; Lipometrix core KU Leuven). This approach enables the detection of mediator lipids, and membrane and storage lipids, of which the latter group represents more complex chemical structures and thus a higher diversity in classification and number of species. Data analysis and paired Wilcoxon rank- sum tests were performed with Python and R 4.3.2.

Results
Across all CD adipose tissue samples, we detected 38 mediator lipid species, and 456 membrane and storage lipid species . When paired-wise comparing creeping fat with MAT far from the diseased ileum, we observed a significant decrease in 16 lipid mediators (p&lt;0.05), namely arachidonic acid (AA), docosahexaenoic acid (DHA), 4 epoxy and 10 hydroxy mediator lipids; with hydroxy mediator X being the top downregulated in creeping fat (fold change (FC)=-2.11, p=0.0003) (Fig. 1B). While AA and DHA are (semi)-essential fatty acids and function as precursors, the other 8 decreased lipids in creeping fat are known to be anti-inflammatory, and 3 (incl. mediator X) are also anti-fibrotic. The lipid mediator profile of MAT close to the proximal unaffected ileum was similar to that of creeping fat, except for a pro-inflammatory lipid being increased in creeping fat (FC=2.30, p=0.004) (Fig. 1B). Lastly, when evaluating the membrane and storage lipid abundances both at species level (sum notation; fatty acyl composition) and at class level, no paired-wise differences among the three adipose tissue locations were found (p&gt;0.05).

Conclusion
In this pilot lipidomics study, we did not observe any changes in storage or membrane lipids in creeping fat as compared to paired unaffected MAT. In contrast, a decrease in anti-inflammatory and anti-fibrotic lipid species along with an increase in a pro-inflammatory species points towards a harmful microenvironment within creeping fat.
P057 Caudovirales may trigger molecular mimicry mechanisms in Crohn’s Disease
Authors: Errico C , Massimino L , Facoetti A , Nicolò S , Cagliani S , Spanò S , Parigi T L , Riva M , Danese S , Ungaro F 
Published: January 2024

Abstract

Background
The gut virome is known to play a role in the development of Crohn's disease (CD), a type of Inflammatory Bowel Disease (IBD). Several years ago, Norman and colleagues observed an expansion of Caudovirales linked to CD pathogenesis, alongside a reduction in bacterial diversity. To delve deeper, we exploited the IBD TaMMA framework and observed a significantly higher abundance of Caudovirales in the CD individuals compared to healthy controls, confirming earlier findings.

Methods
To further examine the involvement of this viral species in various mucosal cell compartments, we conducted flow cytometry cell sorting (FACS) on intestinal biopsies from CD and healthy individuals. Isolated immune and non-immune cells based on population-specific markers, including CD8 and CD4 T cells, B cells, macrophages, dendritic cells, epithelium, endothelium, and fibroblasts underwent transcriptomics and metatranscriptomics.

Results
We identified higher abundance of the Proteus virus Isfahan, belonging to Caudovirales viral order, in CD dendritic cells and CD macrophages compared to their healthy counterparts. Notably, gene ontology (GO) analysis indicated that only CD dendritic cells, fibroblasts, and epithelial cells exhibited compromised biological responses to viral insults compared to their healthy counterparts. In contrast, CD macrophages displayed upregulation of molecular pathways regulating viral processes. This suggests that virome dysbiosis in these cells may contribute to CD pathogenesis by altering their biological functions. We thus wondered whether Proteus virus Isfahan encoded proteins had similarities with the human ones, somehow establishing molecular mimicry justifying the likelihood of the autoimmune nature of CD. We observed sequence homology in the Proteus virus Isfahan and the human thymidylate synthase, RECQ-like DNA helicase, and dCMP deaminase. These viral proteins are likely to be recognized by the immune system by sharing similarities with the human homologs, thus activating autoreactive immune response and establishing the persistent chronic inflammatory environment within CD mucosa. Experiments employing T helper cells in coculture with Proteus virus Isfahan proteins-overexpressing innate immune cells are ongoing to prove the autoreactive activation of the host’s immunity.

Conclusion
Given the growing evidence of viral entities as triggers for IBD, these data could pave the way for discovering viruses directly involved in CD pathogenesis and serving as the booster for molecular mimicry mechanisms, finally providing potential targets for novel intervention strategies that may improve CD management.
P059 GSDMB triggers intestinal inflammation via regulating BHLHA15-mediated hyperactive unfolded protein response
Authors: Gong W , Zhao W 
Published: January 2024

Abstract

Background
Impaired intestinal epithelial barrier has been considered to be associated with an increasing variety of gastrointestinal diseases, especially inflammatory bowel disease (IBD) encompassing Crohn’s disease (CD) and ulcerative colitis (UC). Herein, we investigated the role of Gasdermin B (GSDMB) in modulating intestinal epithelial barrier integrity and proposed a promising therapeutic strategy.

Methods
We generated GSDMB (GSDMBfl/fl;Villin-Cre) intestinal epithelial-specific knock in mice to observe the functions of GSDMB in intestinal epithelial barrier. RNA-seq analysis and human and murine intestine-derived organoids were used to determine the mechanism of function of GSDMB.

Results
To interrogate the intestinal functions of GSDMB in vivo, we generated GSDMB conditional knock in mice (heterozygote: GSDMBfl/-;Villin-Cre; homozygote: GSDMBfl/fl;Villin-Cre) by crossing a mouse line containing the floxed alleles of human GSDMB and a transcriptional stop codon at the transcriptional initiation site (GSDMBfl/fl) with the mouse line expressing Cre-recombinase under control of the Villin promoter (Villin-Cre). GSDMBfl/fl;Villin-Cre mice developed spontaneous enterocolitis and exhibited aberrant intestinal barrier integrity (as shown in the figure). GSDMB prominently provoked cell death of absorptive enterocytes and affected the function of goblet cells and Paneth cells in this setting. Mechanistically, epithelial GSDMB modulated hyperactive unfolded protein response of IECs by up-regulating BHLHA15 to mediate intestinal barrier injury instead of by the invasion of pathogenic microorganisms.

Conclusion
We have uncovered an important and a previously unrecognized role of GSDMB in intestinal inflammation, which represents a potential therapeutic target for IBD.
P070 The influence of Crohn’s disease-derived blood plasma upon anabolic signaling responses to leucine stimulation in skeletal muscle cells in vitro
Authors: Fatani H , Kirkpatrick E , Atherton P , Moran G , Brook M 
Published: January 2024

Abstract

Background
Many Crohn’s Disease (CD) patients have low muscle mass and function (sarcopenia), yet the precise drivers of this pathophysiology are unclear. Positive muscle protein balance is driven by essential amino acids (EAA) that stimulate muscle protein synthesis (MPS), with the EAA leucine (L) playing a key role. However, if circulating factors in CD impact muscle anabolic responses to feeding remain unclear. Our aims were to use plasma from healthy human volunteers (HV) and active CD patients to investigate the impact on anabolic signaling and responses to feeding.

Methods
HV were 32 ± 4 y with a BMI 24 ± 1 and CD 26 ± 3 y with a BMI 23 ± 1 disease duration 5 ± 1 y faecal calprotectin 720 ± 12 ug/g. C2C12 myotubes were treated with 4 conditions of media conditioned with 5% plasma from HV or CD, in addition to being treated ± 5mM L for 4 hrs. Protein content was quantified via nanodrop and muscle anabolic signaling measured via immunoblotting for p-mTORC1 (Ser2448), p-4E-BP1 (Thr37/46) and p-P70S6K1 (Thr389).

Results
Immunoblotting revealed no difference in mTORC1 phosphorylation between HV and CD (HV:18.9 ± 2.7 AU, CD: 19.9 ± 3.2 AU), with no change in response to L treatment (HV:18.0 ± 2.4 AU, CD: 16.6 ± 2.3 AU). There was no difference in P70S6K1 phosphorylation between HV and CD (HV: 33.7 ± 3.2 AU, CD: 28.0 ± 4.7 AU) with both groups showing significant increases in phosphorylation with L treatment (HV: 56.4 ± 4.2 AU (P&lt;0.05), CD: 54.5 ± 9.2 AU (P&lt;0.001)). There was no difference in 4EBP1 phosphorylation between HV and CD (HV: 49.8 ± 6.4 AU, CD: 64.6 ± 7.5 AU) with only HV showing a significant increase in phosphorylation with L (HV: 105.5 ± 8.7 AU (P&lt;0.0001), CD: 47.8 ± 5.3 AU). There was difference in total protein concentration between HV and CD, or with L treatment.

Conclusion
We found CD derived blood plasma did not impact the leucine stimulated increase in P70S6K1 phosphorylation but did result in blunted phosphorylation of 4EBP1. These disparities in anabolic signaling indicate that systemic factors in CD may impact muscle anabolic responses to feeding. Yet, the relationship between anabolic markers and rates of MPS remains complex.
P079 Low-intensity Pulsed Ultrasound reflects the status of mucosal injury and repair through stage-specific miRNAs in experimental model of Ulcerative Colitis
Authors: Pineda Chavez S E , Carriles Linares A , Rizzo G , Wozny M , Cafarelli A , Mori G , Sorriento A , Loy L , Dal Buono A , Gabbiadini R , Bezzio C , Lucchetti D , Sgambato A , Ricotti L , Repici A , Armuzzi A , Vetrano S 
Published: January 2024

Abstract

Background
Diagnosis and therapeutic efficacy monitoring of Ulcerative Colitis (UC) are based on a multidisciplinary approach comprising symptomatology and invasive endoscopic assessment coupled to the histopathological characterization of gut tissue biopsies. New technologies that non-invasively reflect tissue-specific changes remains an unmet need. Here we exploited Low Intensity Pulsed Ultrasound (LIPUS) to induce tissue stage-specific miRNAs in circulating blood as a non-invasive approach to reflect the status of the colonic mucosa in experimental model of colitis.

Methods
Based on our previous study, LIPUS was applied at a frequency of 38 kHz and at an intensity of 0 (as control) or 150 mW/cm2 for 3 min, using a device dedicated for in vivo studies. Acute and chronic colitis were induced in C57BL/6N mice (5 animals/group) by administration of 2 and 2.5% ad libitum dextran sodium sulfate (DSS) respectively in their drinking water for 7 days for the acute and three cycles of 7 days for the chronic model. miRNA array profiling was performed on extracellular vesicles (EVs) isolated from plasma of both acute and chronic models, at both active and remission state, 2 h after LIPUS stimulation. miRNA were correlated to the mucosal status by multiplexed immunofluorescence staining using Opal Multiplex IHC (CD4, CD8, CD68, pan-cytokeratin and CD31 markers) and EVs characterized by MACSplex surface epitope detection.

Results
An enrichment of EVs characterized mainly by stromal and immune cell surface markers was found in both acute and chronic inflammatory states, LIPUS stimulation significantly modulated miRNA profiles and clearly discriminated between active acute and chronic phases. 61 miRNAs in acute and 28 in chronic colitis were specifically and significantly upregulated by LIPUS in the active phase, with a fold change ranging from 2 to 1500 compared to control. Both acute and chronic disease showed a miRNA profile coherent with the active inflammatory state of intestinal mucosa. Only 10 and 23 miRNAs were upregulated in acute and chronic remission respectively. The enhancement of miR-18a-3p and miR-301b-3p in the recovery phases correlated to instetin with reduced immune cell infiltration and epithelial layer regeneration.

Conclusion
An optimal LIPUS dosage that non-invasively targets the colon induces the tissue to release specific miRNAs that reflect the mucosal status. LIPUS may open a new era of non-image ultrasound diagnostics that works as disruptive liquid biopsy allowing the detection of tissue biomarkers for monitoring IBD disease progression.
P082 Downregulated apelin expression in T cells in the setting of Chronic Colitis
Authors: Inoue T , Fushimi M , Yamada D , Watabe T , Watanabe M , Okamoto R , Nagaishi T 
Published: January 2024

Abstract

Background
APJ is a G protein-coupled receptor and was originally found as an orphan receptor. Isolation of apelin (APL) from the alimentary tract was found to be the endogenous ligand for APJ. It has been reported that APL is upregulated in the colonic tissues of a murine model of acute colitis induced by dextran sodium sulfate (DSS), and thus it may be suggested to be associated with the pathogenesis of inflammatory bowel diseases (IBD) in humans. However, the mechanism and function of APL in the context of IBD are still not understood. Here, we analyzed APL expression in an animal model of chronic colitis to define its function in the pathogenesis of IBD.

Methods
Each cell type in the colonic tissue, including epithelial cells and lamina propria lymphocytes, were first isolated from wild type C57BL6 mice (WT) to assess APL expression. Next, naïve T cells isolated from WT were adoptively transferred into Rag deficient mice (Rag-/-) to induce chronic colitis, and then APL expression was measured either in the colonic tissue or in the isolated splenic and colonic CD4+ T cells from these T cell-reconstituted Rag-/- to compare with those of WT or Rag-/- without colitis. In addition, WT naïve T cells were differentiated into either Th1, Th2 or Th17 in vitro to analyze APL expression. Finally, the Rag-/- receiving naïve T cells were administered a synthetic APL peptide, APL-13, to assess the severity of colitis.

Results
Semi-quantitative PCR (qPCR) revealed that CD4+ T cells express relatively higher level of APL compared to other cell types including the epithelial cells in colonic tissue from WT. However, APL expression in the colonic tissues from the Rag-/- induced chronic colitis was unexpectedly downregulated compared to control groups without colitis; this is not consistent with the previous report using acute DSS colitis model. Subsequently, qPCR revealed significantly decreased APL expression in the splenic and colonic T cells from Rag-/- induced colitis compared to that of WT. APL expressions in the effecter T cells in vivo and all of the differentiated T cells in vitro were also significantly downregulated compared to naïve T cells and non-differentiated control T cells, respectively. Given these results, APL-13 was injected into the Rag-/- that underwent T cell reconstitution to antagonize the APL downregulation. This resulted in reduced severity of colitis compared to that of vehicle control-injected group.

Conclusion
These results suggest that T cells can be one of the major sources of APL in colonic tissues, and APL downregulation in effecter T cells may lead to the development of chronic colitis. In addition, this study also suggests that APL may be a novel therapeutic target for IBD.
P098 The Endoscopic Severity Score Map (ESSM): An Artificial Intelligence scoring system providing accurate, objective and localised measurements of endoscopic disease severity in ulcerative colitis
Authors: Gutierrez Becker B , Fraessle S , Yao H , Lüscher J , Girycki R , Machura B , Gośliński J , Czornik J , Pitura M , Arús-Pous J , Fisher E , Bojic D , Richmond D , Bigorgne A , Prunotto M 
Published: January 2024

Abstract

Background
Commonly used scoring schemes as the Mayo Endoscopic Subscore (MES) account for disease severity only at specific (i.e., the worst) segments and do not capture disease extent. However, for an accurate assessment of disease severity in patients with ulcerative colitis (UC), the measure of the precise extent of disease activity is necessary. Alternative systems that include disease extent have been proposed (Balint 2018), but their implementation is prohibited by the time and cost constraints of comprehensively scoring each location along the entire colon. Here, we present the Endoscopic Severity Score Map (ESSM), a scoring system based on Artificial Intelligence, capable of providing an assessment of disease severity and extent in UC in a fully automated manner.

Methods
The ESSM consists of 3 main elements (Fig. 1): 1) a quality algorithm which selects readable frames from a colonoscopy video, 2) a scoring system which assigns an MES to each readable frame (Gutierrez Becker 2020) and 3) a camera localisation algorithm that assigns each frame to an anatomical location within the colon (Yao 2022). The ESSM was trained and tested using 4,306 sigmoidoscopy videos from phase III Etrolizumab clinical trials (Hickory NCT02100696, Laurel NCT02165215, Hibiscus I NCT02163759, Hibiscus II NCT02171429 and Gardenia NCT02136069).

Results
We evaluate the performance of the ESSM by first assessing the agreement of scoring as compared to centrally read MES. The agreement between central reading and the ESSM at the colon section level was high (quadratic-weighted kappa k=0.81; Tab. 1). This was comparable to the agreement between central and local reading (k=0.84), suggesting that the ESSM shows levels of inter-rater variability comparable to experienced readers. Finally, we found correlations between the average ESSM at all anatomical locations and other disease activity markers to be moderate to high: faecal calprotectin rs=0.24, CRP rs=0.29, stool frequency rs=0.49, rectal bleeding rs=0.43 and physician global assessment rs=0.47 (Tab. 1).

Conclusion
Here, we introduced the ESSM, a fully-automated AI-based scoring system that enables accurate, objective and localised assessment of disease severity in UC. In brief, we show that the ESSM compares well with central reading (at the colon section level) and has clinical relevance when compared to other markers of disease activity. This tentatively suggests that the ESSM has the potential to augment the current way of assessing disease severity, both in clinical trials and everyday clinical practice.